Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

The Future of HCC Management

February 28th 2020

Etiologic Reponses to Treating Hepatitis B/C-Related HCC

February 28th 2020

Therapy Options for Hepatitis B/C-Related HCC

February 28th 2020

Treatment Approach After IMpower150 Regimen

February 28th 2020

Relapsed/Refractory HCC: Third-Line Approach

February 28th 2020

I/O Therapy Approach After First-Line Treatment

February 28th 2020

COSMIC-312 Trial Overview

February 28th 2020

MHCC Combination Therapies: Selection and Differentiation

February 28th 2020

Novel Combinations for Treating mHCC

February 28th 2020

IMBrave150 Regimen: Managing Varices

February 28th 2020

IMbrave150 Phase III Trial for MHCC

February 28th 2020

Metastatic HCC: Locoregional to Systemic Therapy

February 28th 2020

Diagnosing Patients With HCC

February 28th 2020

Cirrhosis Prognosis: The Child-Pugh Score

February 28th 2020

NASH and Cirrhosis in HCC

February 28th 2020

Top NY GI Oncologists Spotlight Groundbreaking Research Efforts

February 27th 2020

Experts from Memorial Sloan Kettering Cancer Center and NYU Langone Health’s Perlmutter Cancer Center highlight some of the exciting research efforts being conducted at their respective institutions.

FDA Approvals in HCC and Cervical Cancer, Breakthrough Designation in Lung Cancer, and More

February 26th 2020

The Future of MRD Assessment in CRC

February 26th 2020

Postsurgical ctDNA Surveillance in Locally Advanced CRC

February 26th 2020

Applying MRD Testing in Locally Advanced CRC

February 26th 2020